Newsletter: October 2025 November 14, 2025 Jump To Jump To Subscribe ZERO Run/Walk Unites Communities Against Prostate Cancer Since its inception in 2008 as the "Dash for Dad," the ZERO Prostate Cancer Run/Walk program has consistently supported the prostate cancer community by remaining a constant beacon of hope, breaking down barriers to care, and providing essential resources. Over the years, while many aspects of the event evolved, its core mission remained unchanged. The Run/Walk served as a vital pillar in over 25 cities nationwide, offering a day for those affected by prostate cancer to unite, find comfort, honor loved ones, and celebrate victories. In its 17th year, the program hosted 17 events during Prostate Cancer Awareness Month in September, raising over $2 million to eliminate stigmas and barriers in prostate cancer healthcare. Don't miss the chance to join a Run/Walk event near you. Your support will create a lasting impact on the prostate cancer community. Don't just take it from us! Here's what Peter O'Donnell of the Charlotte Run/Walk has to say about the impact the Run/Walk has had on his life: "After being diagnosed with metastatic prostate cancer in May of 2024, I sought out opportunities where I could support all men and their families by raising money and creating awareness about this disease. The ZERO Prostate Cancer Run/Walk in Charlotte has provided me this opportunity. What a wonderful event! The opportunity to meet other men and their caregivers is also fabulous! It was a great morning!" Find a Run/Walk Near You Reaching New Heights with the ZERO Peaks Challenge This year marked the inaugural ZERO Peaks Challenge, and what a remarkable debut it was! From the summit of Mount Kilimanjaro, our pioneering team of prostate cancer survivors, patients, and supporters achieved something extraordinary. With the incredible support of our community and our Presenting Sponsor, Tolmar, the inaugural Peaks Challenge raised over $500,000 to aid patients and families affected by prostate cancer. A massive shoutout to our incredible participants—you are the heart and soul of this challenge! As we celebrate this groundbreaking achievement, we are already looking forward to the 2026 Peaks Challenge, and we invite you to be part of this exciting journey. Join our information session on October 22nd to learn more about the 2026 Kilimanjaro Peak Challenge and hear from a 2025 participant about their inspiring journey. Next year, we're setting our sights on the breathtaking trails of Machu Picchu in Peru and Mount Kilimanjaro in Africa. Whether you're an experienced climber or a passionate supporter, there's a place for you in this adventure. Join The Hike Today! ZERO360: Now Easier Than Ever to Access Critical Support We're excited to announce that ZERO360, our comprehensive patient support helpline, is now available at 1-844-ZERO360. This easy-to-remember phone number connects patients and families facing prostate cancer with the same dedicated case managers you've come to trust. ZERO360 case managers provide personalized guidance through every aspect of the prostate cancer journey, offering assistance with insurance navigation, medication co-pay support, financial relief for daily expenses, counseling referrals, and benefits advocacy. This vital service is made possible through the generous support of AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson. As Konrad, a ZERO360 caller, shares: "Without the support of ZERO360, I'm afraid I wouldn't have picked up my prescription from the pharmacy." His experience highlights how our case managers help patients overcome financial and insurance barriers to receive life-saving treatment. Remember, alongside ZERO360, our Peer Support network, support groups, and MENtor program continue to ensure no one faces prostate cancer alone. Connect With a ZERO360 Manager Your Voice Matters: Join Us in Washington, D.C. Advocating for prostate cancer has never been more urgent, and now, with research funding on the chopping block, prevention programs at risk, and millions facing the potential loss of access to diagnosis and treatment, the stakes are higher than ever. We need you at the 2026 ZERO Prostate Cancer Advocacy Summit, taking place February 22-24 in Washington, D.C. Despite all of the challenges of 2025, our community proved what's possible when we unite. Together, our victories weren't luck -- they happened because advocates like you raised your voices and made Congress listen. This is the moment to stand up, speak out, and show the power of our community by sharing your story and pushing for change that saves lives. Will you be there? Register for the 2026 Summit Grow. Give. Inspire. Your Way, Any Day. Join us this November for "Grow Your Own Way" (inspired by Grow & Give), where facial hair becomes more than just a style—it's a statement! Whether you're growing a mustache in memory or flaunting a beard to spark awareness, it's your look and it's your choice. This is your opportunity to help connect patients with tailored solutions that alleviate the financial burdens of their diagnosis and provide support, while also distributing vital educational and awareness resources to those in need. Grow Your Own Way invites everyone—company teams, first responders, individuals, and families—to take action on their own terms. So, why wait? Sign up your team today and contribute to this noble cause.» Sign Up Today Team ZERO: Patrick Burns at the Bank of America Chicago Marathon! Join us in cheering on Patrick Burns, a dedicated member of Team ZERO, as he competes in the Chicago Marathon on October 12th. Patrick's journey with prostate cancer began unexpectedly at age 51, when he was diagnosed with an aggressive form of the disease.Despite the challenges, Patrick has shown incredible resilience and commitment to raising awareness and funds for prostate cancer research and support. His goal is to raise $5,000 to aid patients and their families, bringing us closer to Generation ZERO—where no man faces prostate cancer. This year, Team ZERO boasts 30 participants who have collectively raised over $60,000.Team ZERO empowers individuals to make a meaningful impact through endurance events. Interested in making a difference? Join an upcoming marathon in 2026 and become part of this inspiring community. Together, we can create a future where no one faces prostate cancer alone.» Join Team ZERO Use Your Voice on the Patient & Caregiver Advisory Board Applications are currently open for ZERO's Patient & Caregiver Advisory Board (PCAB). If you're a prostate cancer patient or caregiver, submit your application before the October 15 deadline. PCAB members provide crucial insights that shape our programs, identify service gaps, and ensure we're meeting community needs. The board meets virtually 4-6 times annually, with members serving as key ambassadors for ZERO's mission. We especially encourage applications from recently diagnosed patients and those from diverse backgrounds. This is your opportunity to make a meaningful impact on the prostate cancer community.» Apply for the PCAB Join Our ASTRO Recap Webinar Don't miss our upcoming webinar "Key Updates in Radiation Oncology" on October 23 at 4:00 p.m. ET. Dr. Michael Greenberg will share expert insights from the 2025 ASTRO Annual Meeting, covering the latest advancements in radiation oncology, emerging research, and practice-changing clinical updates. This valuable session includes an extended Q&A portion where your questions will be answered directly by Dr. Greenberg. Reserve your spot today for this important update on prostate cancer treatment advances.» Save Your Spot Now (This content is brought to you by Boston Scientific & Foundation Medicine) Learn More About Radiotherapy Explore our four-part video series on radiopharmaceutical treatment, made in partnership with Curium. Each video breaks down the science and shares insights, all in an easy-to-follow format.» Watch the Series (This content is brought to you by Curium) Metastatic Prostate Cancer Clinical Study This clinical trial is enrolling men with advanced prostate cancer that has spread and no longer responds to hormone therapy. SYNC-T Therapy SV-102 combines a procedure that freezes part of a tumor with an infusion of a multi-target drug directly into the tumor, aiming to activate the immune system to fight cancer throughout the body. The trial is evaluating safety, tolerability, and effectiveness. Learn more: ClinicalTrials.gov NCT06533644 or legion100trial.com. (This content is brought to you by Syncromune) The rechARge clinical study is enrolling Are you or a loved one battling metastatic castration-resistant prostate cancer (mCRPC)?The rechARge study is underway to evaluate the effectiveness of an investigational oral study drug (BMS-986365) compared to standard treatments for mCRPC. The study drug is a hormone therapy. Researchers want to better understand: How well the study drug works for individuals with mCRPC What side effects it may have The study drug will be compared to multiple approved treatments for mCRPC, including chemotherapy or a different hormone therapy drug. There is no placebo in this study, so every participant will receive therapy. This study is open-label, meaning that participants and their doctors will know which therapy they are receiving.Click here to see if this study may be an option. (This content is brought to you by Bristol Myers Squibb) Get monthly news, delivered to your inbox Sign up for the monthly ZEROHour Newsletter, and stay updated on prostate cancer news, research, events, and more. Enter your email Where did you learn about us? Newsletter ZEROHour Newsletter More for you
ZERO Run/Walk Unites Communities Against Prostate Cancer Since its inception in 2008 as the "Dash for Dad," the ZERO Prostate Cancer Run/Walk program has consistently supported the prostate cancer community by remaining a constant beacon of hope, breaking down barriers to care, and providing essential resources. Over the years, while many aspects of the event evolved, its core mission remained unchanged. The Run/Walk served as a vital pillar in over 25 cities nationwide, offering a day for those affected by prostate cancer to unite, find comfort, honor loved ones, and celebrate victories. In its 17th year, the program hosted 17 events during Prostate Cancer Awareness Month in September, raising over $2 million to eliminate stigmas and barriers in prostate cancer healthcare. Don't miss the chance to join a Run/Walk event near you. Your support will create a lasting impact on the prostate cancer community. Don't just take it from us! Here's what Peter O'Donnell of the Charlotte Run/Walk has to say about the impact the Run/Walk has had on his life: "After being diagnosed with metastatic prostate cancer in May of 2024, I sought out opportunities where I could support all men and their families by raising money and creating awareness about this disease. The ZERO Prostate Cancer Run/Walk in Charlotte has provided me this opportunity. What a wonderful event! The opportunity to meet other men and their caregivers is also fabulous! It was a great morning!" Find a Run/Walk Near You Reaching New Heights with the ZERO Peaks Challenge This year marked the inaugural ZERO Peaks Challenge, and what a remarkable debut it was! From the summit of Mount Kilimanjaro, our pioneering team of prostate cancer survivors, patients, and supporters achieved something extraordinary. With the incredible support of our community and our Presenting Sponsor, Tolmar, the inaugural Peaks Challenge raised over $500,000 to aid patients and families affected by prostate cancer. A massive shoutout to our incredible participants—you are the heart and soul of this challenge! As we celebrate this groundbreaking achievement, we are already looking forward to the 2026 Peaks Challenge, and we invite you to be part of this exciting journey. Join our information session on October 22nd to learn more about the 2026 Kilimanjaro Peak Challenge and hear from a 2025 participant about their inspiring journey. Next year, we're setting our sights on the breathtaking trails of Machu Picchu in Peru and Mount Kilimanjaro in Africa. Whether you're an experienced climber or a passionate supporter, there's a place for you in this adventure. Join The Hike Today! ZERO360: Now Easier Than Ever to Access Critical Support We're excited to announce that ZERO360, our comprehensive patient support helpline, is now available at 1-844-ZERO360. This easy-to-remember phone number connects patients and families facing prostate cancer with the same dedicated case managers you've come to trust. ZERO360 case managers provide personalized guidance through every aspect of the prostate cancer journey, offering assistance with insurance navigation, medication co-pay support, financial relief for daily expenses, counseling referrals, and benefits advocacy. This vital service is made possible through the generous support of AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson. As Konrad, a ZERO360 caller, shares: "Without the support of ZERO360, I'm afraid I wouldn't have picked up my prescription from the pharmacy." His experience highlights how our case managers help patients overcome financial and insurance barriers to receive life-saving treatment. Remember, alongside ZERO360, our Peer Support network, support groups, and MENtor program continue to ensure no one faces prostate cancer alone. Connect With a ZERO360 Manager Your Voice Matters: Join Us in Washington, D.C. Advocating for prostate cancer has never been more urgent, and now, with research funding on the chopping block, prevention programs at risk, and millions facing the potential loss of access to diagnosis and treatment, the stakes are higher than ever. We need you at the 2026 ZERO Prostate Cancer Advocacy Summit, taking place February 22-24 in Washington, D.C. Despite all of the challenges of 2025, our community proved what's possible when we unite. Together, our victories weren't luck -- they happened because advocates like you raised your voices and made Congress listen. This is the moment to stand up, speak out, and show the power of our community by sharing your story and pushing for change that saves lives. Will you be there? Register for the 2026 Summit Grow. Give. Inspire. Your Way, Any Day. Join us this November for "Grow Your Own Way" (inspired by Grow & Give), where facial hair becomes more than just a style—it's a statement! Whether you're growing a mustache in memory or flaunting a beard to spark awareness, it's your look and it's your choice. This is your opportunity to help connect patients with tailored solutions that alleviate the financial burdens of their diagnosis and provide support, while also distributing vital educational and awareness resources to those in need. Grow Your Own Way invites everyone—company teams, first responders, individuals, and families—to take action on their own terms. So, why wait? Sign up your team today and contribute to this noble cause.» Sign Up Today Team ZERO: Patrick Burns at the Bank of America Chicago Marathon! Join us in cheering on Patrick Burns, a dedicated member of Team ZERO, as he competes in the Chicago Marathon on October 12th. Patrick's journey with prostate cancer began unexpectedly at age 51, when he was diagnosed with an aggressive form of the disease.Despite the challenges, Patrick has shown incredible resilience and commitment to raising awareness and funds for prostate cancer research and support. His goal is to raise $5,000 to aid patients and their families, bringing us closer to Generation ZERO—where no man faces prostate cancer. This year, Team ZERO boasts 30 participants who have collectively raised over $60,000.Team ZERO empowers individuals to make a meaningful impact through endurance events. Interested in making a difference? Join an upcoming marathon in 2026 and become part of this inspiring community. Together, we can create a future where no one faces prostate cancer alone.» Join Team ZERO Use Your Voice on the Patient & Caregiver Advisory Board Applications are currently open for ZERO's Patient & Caregiver Advisory Board (PCAB). If you're a prostate cancer patient or caregiver, submit your application before the October 15 deadline. PCAB members provide crucial insights that shape our programs, identify service gaps, and ensure we're meeting community needs. The board meets virtually 4-6 times annually, with members serving as key ambassadors for ZERO's mission. We especially encourage applications from recently diagnosed patients and those from diverse backgrounds. This is your opportunity to make a meaningful impact on the prostate cancer community.» Apply for the PCAB Join Our ASTRO Recap Webinar Don't miss our upcoming webinar "Key Updates in Radiation Oncology" on October 23 at 4:00 p.m. ET. Dr. Michael Greenberg will share expert insights from the 2025 ASTRO Annual Meeting, covering the latest advancements in radiation oncology, emerging research, and practice-changing clinical updates. This valuable session includes an extended Q&A portion where your questions will be answered directly by Dr. Greenberg. Reserve your spot today for this important update on prostate cancer treatment advances.» Save Your Spot Now (This content is brought to you by Boston Scientific & Foundation Medicine) Learn More About Radiotherapy Explore our four-part video series on radiopharmaceutical treatment, made in partnership with Curium. Each video breaks down the science and shares insights, all in an easy-to-follow format.» Watch the Series (This content is brought to you by Curium) Metastatic Prostate Cancer Clinical Study This clinical trial is enrolling men with advanced prostate cancer that has spread and no longer responds to hormone therapy. SYNC-T Therapy SV-102 combines a procedure that freezes part of a tumor with an infusion of a multi-target drug directly into the tumor, aiming to activate the immune system to fight cancer throughout the body. The trial is evaluating safety, tolerability, and effectiveness. Learn more: ClinicalTrials.gov NCT06533644 or legion100trial.com. (This content is brought to you by Syncromune) The rechARge clinical study is enrolling Are you or a loved one battling metastatic castration-resistant prostate cancer (mCRPC)?The rechARge study is underway to evaluate the effectiveness of an investigational oral study drug (BMS-986365) compared to standard treatments for mCRPC. The study drug is a hormone therapy. Researchers want to better understand: How well the study drug works for individuals with mCRPC What side effects it may have The study drug will be compared to multiple approved treatments for mCRPC, including chemotherapy or a different hormone therapy drug. There is no placebo in this study, so every participant will receive therapy. This study is open-label, meaning that participants and their doctors will know which therapy they are receiving.Click here to see if this study may be an option. (This content is brought to you by Bristol Myers Squibb)
Get monthly news, delivered to your inbox Sign up for the monthly ZEROHour Newsletter, and stay updated on prostate cancer news, research, events, and more. Enter your email Where did you learn about us?
